The prevalence of glaucoma in the Melbourne Visual Impairment Project

Ophthalmology
M D WensorH R Taylor

Abstract

The purpose of the study was to determine the prevalence of glaucoma in Melbourne, Australia. All subjects were participants in the Melbourne Visual Impairment Project (Melbourne VIP), a population-based prevalence study of eye disease that included residential and nursing home populations. Each participant underwent a standardized eye examination, which included a Humphrey Visual Field test, applanation tonometry, fundus examination including fundal photographs, and a medical history interview. Glaucoma status was determined by a masked assessment and consensus adjudication of visual fields, optic disc photographs, intraocular pressure, and glaucoma history. A total of 3271 persons (83% response rate) participated in the residential Melbourne VIP. The overall prevalence rate of definite primary open-angle glaucoma in the residential population was 1.7% (95% confidence limits = 1.21, 2.21). Of these, 50% had not been diagnosed previously. Only two persons (0.1%) had primary angle-closure glaucoma and six persons (0.2%) had secondary glaucoma. The prevalence of glaucoma increased steadily with age from 0.1% at ages 40 to 49 years to 9.7% in persons aged 80 to 89 years. There was no relationship with gender. The authors examined ...Continue Reading

References

Feb 1, 1987·American Heart Journal·J L Breslow
Oct 1, 1966·The British Journal of Ophthalmology·F C Hollows, P A Graham
Jan 1, 1981·The British Journal of Ophthalmology·B Bengtsson
May 1, 1994·Australian and New Zealand Journal of Ophthalmology·I M YoungH R Taylor
Jan 1, 1993·The British Journal of Ophthalmology·M CoffeyP Courtney
Dec 1, 1994·Ophthalmic Epidemiology·P M LivingstonH R Taylor
Mar 9, 1994·Current Opinion in Ophthalmology·R P Crick
Feb 1, 1963·Journal of Chronic Diseases·N B BELLOC

❮ Previous
Next ❯

Citations

Apr 14, 2004·Archives of Ophthalmology·David S FriedmanUNKNOWN Eye Diseases Prevalence Research Group
Jul 24, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Carl ErbDieter Schremmer
Dec 4, 2003·American Journal of Ophthalmology·Orna GeyerPeretz Lavie
Jun 5, 2002·Ophthalmology·Bickol N MukeshHugh R Taylor
May 17, 2003·Ophthalmology·Anselm HennisUNKNOWN Barbados Eye Studies Group
Nov 24, 2005·Eye·A Rotchford
Sep 14, 1999·Australian and New Zealand Journal of Ophthalmology·F Hourihan, P Mitchell
Sep 12, 2000·Clinical & Experimental Ophthalmology·L WeihH R Taylor
Sep 12, 2000·Clinical & Experimental Ophthalmology·E Rochtchina, P Mitchell
Oct 24, 2003·International Ophthalmology Clinics·Samantha Fraser-Bell, Rohit Varma
Mar 15, 2012·Menopause : the Journal of the North American Menopause Society·Thasarat S Vajaranant, Louis R Pasquale
Jul 31, 1998·Australian and New Zealand Journal of Ophthalmology·L M WeihH R Taylor
Dec 17, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Algis J Vingrys
Dec 11, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·David M Cockburn
Dec 11, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Algis J Vingrys
Dec 11, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Anthony JH Hall
Jan 19, 2008·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Alberto DiazMa Jesus Giraldez
Feb 21, 2006·The British Journal of Ophthalmology·H A Quigley, A T Broman
Jul 11, 2006·The British Journal of Ophthalmology·Z MimiwatiJ E Richards
Jul 25, 2000·The British Journal of Ophthalmology·R McKayH R Taylor
Feb 27, 2001·The British Journal of Ophthalmology·H R Taylor, J E Keeffe
Feb 27, 2001·The British Journal of Ophthalmology·C A McCartyH R Taylor
Jan 22, 2002·The British Journal of Ophthalmology·N G CongdonA T Broman
Jan 22, 2002·The British Journal of Ophthalmology·Jill E KeeffeHugh R Taylor
Aug 20, 2002·The British Journal of Ophthalmology·M KroeseD McCarter
May 29, 2003·The British Journal of Ophthalmology·G GazzardS Seah
Aug 23, 2003·Journal of Epidemiology and Community Health·M Kroese, H Burton
Jan 10, 2013·PloS One·David FleischmanR Rand Allingham
May 20, 2014·PloS One·Nikki J RubinsteinAllison M McKendrick
Nov 30, 1999·Lancet·A L Coleman
Jan 1, 2011·ISRN Ophthalmology·Megan Boyle-WalkerPatti Fuhr
May 20, 2014·Survey of Ophthalmology·Hyun-Kyung Cho, Changwon Kee
Jan 11, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Emmanuelle SouzeauJamie E Craig
Aug 8, 2014·Current Opinion in Allergy and Clinical Immunology·Brett Bielory, Leonard Bielory
Dec 3, 2014·Progress in Retinal and Eye Research·Corey A Smith, Balwantray C Chauhan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.